KRAS and lung cancer: Based on studies reporting a correlation between Stk11 loss and Il-6 upregulation in mouse models of Kras-driven lung cancers in vivo [12], we compared IL-6 expression between STK11 WT (aka “Parent”) and matched STK11-KO human LUAD cells using qRT-PCR.